CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.

Saved in:
Bibliographic Details
Title: CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.
Authors: Seligson ND; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States.; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States., Zhang X; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States., Zemanek MC; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States., Johnson JA; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States., VanGundy Z; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States., Wang D; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, United States., Phelps MA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, United States., Roddy J; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States.; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States., Hofmeister CC; Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States., Li J; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH, United States., Poi MJ; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH, United States.; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 Jan 08; Vol. 14, pp. 1334440. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-9812
DOI:10.3389/fphar.2023.1334440